These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10482637

  • 1. Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo.
    Sanna PP, Deerinck TJ, Ellisman MH.
    J Virol; 1999 Oct; 73(10):8817-23. PubMed ID: 10482637
    [Abstract] [Full Text] [Related]

  • 2. Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.
    Mikloska Z, Sanna PP, Cunningham AL.
    J Virol; 1999 Jul; 73(7):5934-44. PubMed ID: 10364346
    [Abstract] [Full Text] [Related]

  • 3. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH, Oakes JE, Lausch RN.
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [Abstract] [Full Text] [Related]

  • 4. Difficulties imaging herpes simplex keratitis with fluorescein isothiocynate-labeled anti-HSV-1 antibodies in an ex vivo model.
    Novitskaya ES, McGilligan VE, Moore JE, Sharma A, Dean SJ, Moore TC.
    Cornea; 2009 May; 28(4):421-5. PubMed ID: 19411961
    [Abstract] [Full Text] [Related]

  • 5. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.
    Sanna PP, De Logu A, Williamson RA, Hom YL, Straus SE, Bloom FE, Burton DR.
    Virology; 1996 Jan 01; 215(1):101-6. PubMed ID: 8553581
    [Abstract] [Full Text] [Related]

  • 6. The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.
    Loiacono CM, Taus NS, Mitchell WJ.
    J Neurovirol; 2003 Jun 01; 9(3):336-45. PubMed ID: 12775417
    [Abstract] [Full Text] [Related]

  • 7. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K, Namazue J, Campo-Vera H, Ogino T, Yamanishi K.
    Virology; 1986 Feb 01; 149(1):74-82. PubMed ID: 2418583
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 9. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 10. Characterization of polyclonal antibodies to Herpes Simplex Virus types 1 and 2.
    Lloyd J, Copaciu R, Yahyabeik A, DeWit C, Cummings K, Lacey M, Su Q.
    J Histotechnol; 2019 Dec 01; 42(4):202-214. PubMed ID: 31680648
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA, Srivastava R, Chentoufi AA, Geertsema R, Thai NT, Dasgupta G, Osorio N, Kalantari M, Nesburn AB, Wechsler SL, BenMohamed L.
    J Virol; 2015 Jul 01; 89(13):6619-32. PubMed ID: 25878105
    [Abstract] [Full Text] [Related]

  • 12. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
    Li L, Li Z, Wang E, Yang R, Xiao Y, Han H, Lang F, Li X, Xia Y, Gao F, Li Q, Fraser NW, Zhou J.
    J Virol; 2016 Jan 15; 90(2):790-804. PubMed ID: 26512084
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus.
    Conraths FJ, Pauli G, Ludwig H.
    Virus Res; 1988 Apr 15; 10(1):53-63. PubMed ID: 2837013
    [Abstract] [Full Text] [Related]

  • 14. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
    Criscuolo E, Castelli M, Diotti RA, Amato V, Burioni R, Clementi M, Ambrosi A, Mancini N, Clementi N.
    J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30867302
    [Abstract] [Full Text] [Related]

  • 15. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ.
    J Virol; 2015 Sep 01; 89(18):9213-31. PubMed ID: 26109729
    [Abstract] [Full Text] [Related]

  • 16. The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.
    Lubinski JM, Lazear HM, Awasthi S, Wang F, Friedman HM.
    J Virol; 2011 Apr 01; 85(7):3239-49. PubMed ID: 21228231
    [Abstract] [Full Text] [Related]

  • 17. Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8+ T Cells in a Murine Model of Ocular Infection.
    Lahmidi S, Yousefi M, Dridi S, Duplay P, Pearson A.
    J Virol; 2017 Aug 01; 91(15):. PubMed ID: 28490594
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants.
    Liljeqvist JÅ, Trybala E, Hoebeke J, Svennerholm B, Bergström T.
    J Gen Virol; 2002 Jan 01; 83(Pt 1):157-165. PubMed ID: 11752712
    [Abstract] [Full Text] [Related]

  • 19. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1.
    Grabowska A, Jameson C, Laing P, Jeansson S, Sj Gren-Jansson E, Taylor J, Cunningham A, Irving WL.
    J Gen Virol; 1999 Jul 01; 80 ( Pt 7)():1789-1798. PubMed ID: 10423148
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.
    De Logu A, Williamson RA, Rozenshteyn R, Ramiro-Ibañez F, Simpson CD, Burton DR, Sanna PP.
    J Clin Microbiol; 1998 Nov 01; 36(11):3198-204. PubMed ID: 9774565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.